Related Experiment Video
Updated: Nov 23, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
COVID-19 and paediatric patient involvement (cardiovascular aspects)
Jan Müller1,2, Renate Oberhoffer1,2, Leon Brudy1
1Department of Pediatric Cardiology and Congenital Heart Defects German Heart Center Munich Technical University Munich Lazarettstr. 36 80363 Munich, Germany.
Abstract:
The majority of children with COVID-19 infections, fortunately, shows only milder symptoms. Which however has led that they are considered only for their particular transmission potential. Nevertheless, cases with Multisystem Inflammatory Syndrome in Children and Kawasaki Disease with quite specific COVID-19 involvement have been reported and should be taken seriously. In addition, there are many children with a chronic pre-existing condition such as congenital heart disease, cancer, or lung disease who may be at risk for a severe course of COVID-19 when infected. Protecting these children, and children in general, should be a top priority, as these patients will have to live the rest of their long lives with possible sequelae of COVID-19.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Rheumatic Heart Disease III: Medical Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism

